Veracol

Ország: Új-Zéland

Nyelv: angol

Forrás: Medsafe (Medicines Safety Authority)

Aktív összetevők:

Ceftriaxone sodium 298mg (Present as 0.298g ceftriaxone Na*3.5H2O. Eq 0.269g of ceftriaxone Na anhyd or 0.25g ceftriaxone anhy); Lidocaine hydrochloride monohydrate 21.32mg equivalent to lidocaine 20 mg

Beszerezhető a:

Multichem NZ Limited

INN (nemzetközi neve):

Ceftriaxone sodium 298 mg (Present as 0.298g ceftriaxone Na*3.5H2O. Eq 0.269g of ceftriaxone Na anhyd or 0.25g ceftriaxone anhy)

Adagolás:

250 mg

Gyógyszerészeti forma:

Injection with diluent

Összetétel:

Active: Ceftriaxone sodium 298mg (Present as 0.298g ceftriaxone Na*3.5H2O. Eq 0.269g of ceftriaxone Na anhyd or 0.25g ceftriaxone anhy) Lidocaine hydrochloride monohydrate 21.32mg equivalent to lidocaine 20 mg Excipient: Water for injection

db csomag:

Ampoule, glass, lidocaine, 1 ampoule, 2 mL

Osztály:

Prescription

Recept típusa:

Prescription

Gyártó:

Orchid Chemicals and Pharmaceuticals Limited

Termék összefoglaló:

Package - Contents - Shelf Life: Ampoule, glass, lidocaine, 1 ampoule - 2 mL - 36 months from date of manufacture stored at or below 25°C protect from light and moisture - Combination pack, 1 vial + 1 ampoule - 1 dose units - 36 months from date of manufacture stored at or below 25°C protect from light and moisture - Vial, glass, single dose, ceftriaxone, 1 vial - 250 mg - 36 months from date of manufacture stored at or below 25°C protect from light and moisture. reconstituted: 12hrs below 25°C, 24hrs between 2 and 8°C

Engedély dátuma:

2002-12-04

Termékjellemzők

NEW ZEALAND DATA SHEET
VERACOL
Ceftriaxone sodium sterile Ph Eur, powder for injection, 250 mg, 500
mg, 1 g (as ceftriaxone)
Ceftriaxone sodium sterile Ph Eur, powder for infusion, 2 g (as
ceftriaxone)
Page 1 of 13
PRESENTATION
An almost white or yellowish crystalline sterile powder aseptically
filled into glass vials.
Vials contain a controlled quantity of ceftriaxone sodium sterile
equivalent to ceftriaxone
250 mg, 500 mg, 1 g or 2 g.
USES
PHARMACOTHERAPEUTIC GROUP
J01DD04: member of J01DD – Third generation cephalosporins, a subset
of J01D –
other beta-lactam antibacterials.
ACTIONS
Ceftriaxone is a long acting, broad-spectrum cephalosporin antibiotic
for parenteral use.
The bactericidal activity of ceftriaxone results from the inhibition
of bacterial cell wall
synthesis ultimately leading to bacterial lysis. Ceftriaxone is highly
stable to most beta-
lactamases, both penicillinases and cephalosporinases, of
Gram-positive and Gram-
negative bacteria. Ceftriaxone is usually active against the following
bacterial pathogens
_in vitro_ and in clinical infections (refer to Uses - Indications).
Susceptible
Gram-positive
aerobes:
_Staphylococcus _
_aureus_
(methicillin-sensitive);
Staphylococci coagulase-negative; _ Streptococcus pyogenes_
(beta-hemolytic, group A);
_Streptococcus agalactiae_ (beta-hemolytic, group B); Streptococci
beta-hemolytic (non-
group A or B); _Streptococcus viridans_; _Streptococcus pneumoniae_.
Note: Methicillin-resistant _Staphylococcus_ spp. are resistant to
cephalosporins, including
ceftriaxone.
In
general,
_Enterococcus _
_faecalis_,
_Enterococcus _
_faecium_
and
_Listeria _
_monocytogenes_ are resistant.
Susceptible
Gram-negative
aerobes:
_Acinetobacter _
_lwoffi_;
_Acinetobacter _
_anitratus_
(mostly
_A. _
_baumanii_)[1];
_Aeromonas _
_hydrophila_;
_Alcaligenes _
_faecalis_;
_Alcaligenes _
_odorans_; _Alcaligenes-_like bacteria;_ Capnocytophaga _spp.;_
Citrobacter diversus _(including
_C. amalonaticus_);_ Citrobacter freundii_[1];_ Escherichia coli_; _
Enterobacter aerogenes_[1];_